Tap Into the $65B 'Shroom Boom'

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

ICLR
Icon Plc
NASDAQ
157.85
Open 157.85 Prev Close 157.85
High 157.85 Low 157.85
Volume 0 Volume (Avg) 1,438
52 Week High 328.35 52 Week Low 125.10
Market Cap 12.3B PE Ratio 16.22

Shares Stats

Shares Outstanding77,770,000
Shares Float77,270,000
Shares Short2,220,000
Insider Holdings65%
Institution Holdings96.88%

About Icon Plc

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

General

NameIcon Plc
TickerICLR
ExchangeNASDAQ
SectorHealthcare
IndustryDiagnostics & Research
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees39,900

Highlights

Analyst Target218.27
Market Cap12,276,300,000
PE Ratio16.22
PEG Ratio1.12
EBITDA1,551,101,056

Financials

Curr Year EPS Estimate13.30
Next Quarter EPS Estimate3.36
Profit Margin9.82%
Operating Margin14.43
Return on Assets0.04
Return on Equity0.08
Revenue8.1B
Earnings Per Share9.87
Revenue Per Share99.75
Gross Profit2,318,731,008
Quarterly Revenue Growth-0.05

Valuation

Trailing PE15.99
Forward PE11.67
Price/Sales (Trailing 12 Mt.)1.52
Price/Book (Most Recent Quarter)1.27

Earnings

Most Popular

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert

Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

New Jersey US Attorney Fired After Being Chosen Over Former Trump Lawyer Alina Habba

The U.S. Attorney for the District of New Jersey, Desiree Leigh Grace, has been dismissed by the Justice Department.

Russia insists on achieving Ukraine goals despite Trump's ultimatum

Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Trump to visit Federal Reserve headquarters as feud with its chair continues

WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Trump-Backed DOJ Motion Seeks Release Of Jeffrey Epstein, Maxwell Grand Jury Transcripts

DOJ moves to unseal grand jury testimony related to Jeffrey Epstein and Ghislaine Maxwell following criticism over handling of documents.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Nvidia's CEO Hits Beijing Like A Rockstar, Stirs Jensen-Mania In China

Nvidia CEO Jensen Huang receives a rockstar reception in Beijing during his most recent visit last week.

TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook

TransMedics Group shares are rising in Wednesday's after-hours session after the company reported financial results for the second quarter.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

What we know about a new health data tracking system being announced by White House

WASHINGTON (AP) — President Donald Trump's planned announcement Wednesday of a that would make it easier for patients to access their health records and monitor their wellness is raising a host of privacy concerns.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Britain and Australia to sign 50-year nuclear submarine treaty

MELBOURNE, Australia (AP) — Britain and Australia announced they will sign a cooperation treaty to build Australian nuclear-powered submarines and welcomed a review by administration of the United States' role in the trilateral defense deal.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Ethereum, XRP, SOL Surge After GENIUS Act: What's Driving The Altcoin Rally?

The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto legislation to date, ushering in structural clarity for digital assets.

Oklo Stock Hit A New 52-Week High Today: What's Driving The Action?

Shares of advanced nuclear technology company Oklo are trading higher Thursday. The company announced a strategic alliance with Liberty Energy on Wednesday.

Is Your Capital Following a Real Strategy? - Ad

Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Europe's central bank to hold off on another rate cut until it knows how bad the tariff blow will be

FRANKFURT, Germany (AP) — The European Central Bank will likely hold off on making another interest rate cut Thursday, choosing to wait until it can measure the size of any economic blow from .

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Millions Over Morals: Survey Reveals Americans' Willingness To Sacrifice Love And Loyalty For Cash

A recent poll has uncovered that a significant number of Americans would willingly forsake love, betray friends, and even risk their own lives for a million-dollar windfall.

A US judge says arrested Haitian businessman and former presidential hopeful will remain in custody

SAN JUAN, Puerto Rico (AP) — A federal immigration judge in Miami ordered on Thursday that wealthy remain in custody in the United States, where he is held over accusations of supporting .

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Beef: It's What's for Dinner — If You Can Afford It

Here's a look at why beef is the latest item driving grocery bills higher.

Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal

TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright traderelite.club
Privacy Policy | Terms of Service